🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

14,283 results for “B” Clear

  1. Abemaciclib, Lasofoxifene, Fulvestrant

    Lacuna Pharma Pty Ltd

    Locally advanced or metastatic breast cancer

    phase 3 small molecule active

    1 trial

  2. Abicipar Pegol

    Allergan Pharmaceuticals International Limited

    Macular Degeneration

    phase 3 small molecule completed

    1 trial

  3. Abiraterone - Usual

    Lxo Ireland Designated Activity Company

    Prostate Cancer

    phase 3 small molecule active

    1 trial

  4. Abraxane 5 mg/ml powder for dispersion for infusion., CISPLATIN , PEMBROLIZUMAB, CARBOPLATIN , PACLITAXEL , PEMETREXED

    Fondazione Telethon ETS

    metastatic NSCLC patients

    phase 3 small molecule active

    1 trial

  5. Abraxane 5 mg/ml powder for dispersion for infusion., Onivyde pegylated liposomal 4.3 mg/ml concentrate for dispersion for infusion, Fluorouracil Accord 50 mg/ml šķīdums injekcijām vai infūzijām, CALCIUM FOLINATE , GEMCITABINE ACCORD 100 mg/ml, solution à diluer pour perfusion, Oxaliplatin Accord 5 mg/ml Konzentrat zur Herstellung einer Infusionslösung

    Ipsen

    Metastatic Pancreatic Adenocarcinoma

    phase 3 small molecule active

    1 trial

  6. Abraxane 5 mg/ml powder for dispersion for infusion., Paclitaxel 6 mg/ml concentrate for solution for infusion, Carboplatin 10 mg/ml concentrate for solution for infusion, Trodelvy 200 mg powder for concentrate for solution for infusion, Gemcitabine 38 mg/mL concentrate for solution for infusion

    Gilead Sciences Pty Limited

    PD-L1-negative metastatic triple-negative breast cancer or PD-L1-positive metastatic triple-negative breast cancer previously treated with an anti-PD-(L)1 agent in the curative setting

    phase 3 small molecule active

    1 trial

  7. Abrocitinib

    Pfizer Australia Pty Ltd

    Moderate-to-Severe Atopic Dermatitis

    phase 3 small molecule active

    1 trial

  8. Abrocitinib Placebo, Abrocitinib

    Pfizer Australia Pty Ltd

    Moderate-to-Severe Atopic Dermatitis

    phase 3 small molecule active

    1 trial

  9. Acalabrutinib

    AstraZeneca

    Untreated Chronic Lymphocytic Leukemia

    phase 3 small molecule active

    1 trial

  10. Aceclidine+Brimonidine combination ophthalmic solution

    LENZ Therapeutics

    Presbyopia

    phase 3 small molecule completed

    6 trials

  11. Aceneuramic Acid Extended-Release Tablets

    Ultragenyx UK Limited

    Hereditary Inclusion Body Myopathy

    phase 3 small molecule terminated

    1 trial

  12. Acetadote EF (Ethylenediaminetetraacetic Acid (EDTA) - Free)

    CUMBERLAND PHARMACEUTICALS INC

    Acetaminophen Overdose

    phase 3 small molecule terminated

    1 trial

  13. Aclidinium bromide/formoterol Fixed-Dose Combination

    AstraZeneca

    COPD

    phase 3 small molecule completed

    1 trial

  14. Aclidinium bromide/formoterol Fixed-Dose Combination (FDC)

    AstraZeneca

    Chronic Obstructive Pulmonary Disease

    phase 3 small molecule completed

    1 trial

  15. Acoramidis

    BridgeBio Oncology Therapeutics

    Amyloidosis

    phase 3 small molecule active

    3 trials

  16. Acoramidis

    BridgeBio Oncology Therapeutics

    Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy

    phase 3 small molecule terminated

    1 trial

  17. Acoramidis (AG10)

    BridgeBio Oncology Therapeutics

    Amyloid Cardiomyopathy, Transthyretin-Related

    phase 3 small molecule active

    1 trial

  18. Acoramidis (AG10)

    BridgeBio Oncology Therapeutics

    Amyloidosis in Transthyretin (TTR)

    phase 3 small molecule active

    1 trial

  19. Actilyse, polvo y disolvente para solución inyectable y para perfusión, Actilyse, polvo y disolvente para solución inyectable y para perfusión

    The George Institute

    People with acute ischemic stroke (AIS) due to large vessel occlusion of the anterior circulation.

    phase 3 small molecule active

    1 trial

  20. Active Surveillance

    Blackmores Limited

    Muscle-Invasive Bladder Carcinoma

    phase 3 other active

    1 trial

  21. Active referral

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking

    phase 3 other active

    1 trial

  22. Acyclovir

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    phase 3 small molecule completed

    1 trial

  23. Adalimumab

    AbbVie

    Juvenile Psoriatic Arthritis

    phase 3 small molecule active

    1 trial

  24. Adalimumab

    AbbVie

    Psoriatic Arthritis

    phase 3 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources